Search results for "Sleeve gastrectomy"

showing 6 items of 6 documents

Roux-en-Y Gastric Bypass as an Effective Bariatric Revisional Surgery after Restrictive Procedures

2020

<b><i>Introduction:</i></b> Revisional surgery must be considered when insufficient weight loss is attained or weight is subsequently regained. This study aimed to investigate the value of Roux-en-Y gastric bypass (RYGB) as a revisional procedure after restrictive surgery. <b><i>Materials and Methods:</i></b> An observational, retrospective study including patients initially operated on for morbid obesity with restrictive techniques (vertical-banded gastroplasty [VBG], adjustable gastric band [AGB], and sleeve gastrectomy) and reoperated with RYGB in our centre between December 1994 and January 2019. Demographic and anthropometric data, associ…

0301 basic medicineAdultReoperationSleeve gastrectomymedicine.medical_specialtyHealth (social science)Gastroplastymedicine.medical_treatmentGastric bypassGastric BypassPulmonary diseaseBariatric Surgerylcsh:TX341-641030209 endocrinology & metabolismComorbidity03 medical and health sciences0302 clinical medicineWeight lossPhysiology (medical)Weight LossmedicineHumansAdjustable gastric bandIntraoperative Complicationslcsh:RC620-627Retrospective Studies030109 nutrition & dieteticsbusiness.industryMortality rateRetrospective cohort studyLength of StayMiddle AgedRoux-en-Y anastomosisSurgeryObesity Morbidlcsh:Nutritional diseases. Deficiency diseasesconversion surgeryinsufficient weight lossmedicine.symptombusinesslcsh:Nutrition. Foods and food supplyResearch Article
researchProduct

Revisional bariatric surgery due to failure of the initial technique: 25 years of experience in a specialized Unit of Obesity Surgery in Spain.

2019

Abstract Objectives To evaluate the effectiveness of conversion surgery in a bariatric surgery unit with 25 years of experience. Method Retrospective observational study of patients with type II obesity or higher who were reoperated by means of conversion surgery due to weight regain, residual body mass index (BMI) >35 kg/m2 or Results A total of 112 patients were included, with a mean age of 40.2 years, who initially underwent vertical banded gastroplasty (VBG) (32.1%), gastric banding (GB) (23.2%), Roux-en-Y gastric bypass (RYGB) (21.4%) and sleeve gastrectomy (SG) (23.2%). The conversion techniques, with a median time between the two surgeries of 70 months, included: RYGB, SG, one-anasto…

AdultMaleReoperationmedicine.medical_specialtySleeve gastrectomyTime FactorsGastroplastymedicine.medical_treatmentGastric BypassAftercareBariatric SurgeryComorbidity030230 surgeryWeight Gain03 medical and health sciences0302 clinical medicinePostoperative ComplicationsWeight lossGastrectomyWeight LossMedicineHumansMass indexTreatment FailurePerioperative PeriodBiliopancreatic DiversionRetrospective StudiesAnthropometrybusiness.industryMortality rateAnastomosis SurgicalGeneral EngineeringRetrospective cohort studyPerioperativeMiddle Agedmedicine.diseaseBiliopancreatic DiversionObesitySurgeryObesity MorbidSpainFemalemedicine.symptombusinessCirugia espanola
researchProduct

Single-centre, triple-blinded, randomised, 1-year, parallel-group, superiority study to compare the effects of Roux-en-Y gastric bypass and sleeve ga…

2019

IntroductionBariatric surgery is increasingly recognised as an effective treatment option for subjects with type 2 diabetes and obesity; however, there is no conclusive evidence on the superiority of Roux-en-Y gastric bypass or sleeve gastrectomy. The Oseberg study was designed to compare the effects of gastric bypass and sleeve gastrectomy on remission of type 2 diabetes and β-cell function.Methods and analysisSingle-centre, randomised, triple-blinded, two-armed superiority trial carried out at the Morbid Obesity Centre at Vestfold Hospital Trust in Norway. Eligible patients with type 2 diabetes and obesity were randomly allocated in a 1:1 ratio to either gastric bypass or sleeve gastrecto…

Malemedicine.medical_specialtySleeve gastrectomyβ-cell functionmedicine.medical_treatment1843Gastric BypassBariatric Surgery030209 endocrinology & metabolismType 2 diabeteslaw.invention03 medical and health sciences0302 clinical medicineSuperiority TrialRandomized controlled trialClinical ProtocolslawGastrectomyDiabetes mellitusInternal medicineInsulin-Secreting CellsmedicineProtocolHumans030212 general & internal medicine1506VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Kardiologi: 771Glycated Hemoglobinbusiness.industryNorwayGeneral Medicinemedicine.diseaseRoux-en-Y anastomosismorbid obesityObesity MorbidDiabetes and EndocrinologyTreatment OutcomeDiabetes Mellitus Type 2GastrectomyFemaleLaparoscopytype 2 diabetesbusinessEpidemiologic MethodsBody mass indexrandomised controlled trialsleeve gastrectomy
researchProduct

A106 Gastroesophageal reflux disease in patients with severe obesity and type 2 diabetes one year after sleeve gastrectomy or Roux-en-Y gastric bypas…

2019

Sleeve gastrectomymedicine.medical_specialtybusiness.industrymedicine.medical_treatmentGastric bypassRefluxType 2 diabetesDiseasemedicine.diseaseRoux-en-Y anastomosislaw.inventionSurgeryRandomized controlled triallawMedicineSurgeryIn patientbusinessSurgery for Obesity and Related Diseases
researchProduct

Do we understand the pathophysiology of GERD after sleeve gastrectomy?

2020

Gastroesophageal reflux disease (GERD), a prevalent problem among obese individuals, is strongly associated with obesity and weight loss. Hence, bariatric surgery effectively improves GERD for many patients. Depending on the type of bariatric procedure, however, surgery can also worsen or even cause a new onset of GERD. As a consequence, GERD remains a relevant problem for many bariatric patients, and especially those who have undergone sleeve gastrectomy (SG). Affected patients report not only a decrease in physical functioning but also suffer from mental and emotional problems, resulting in poorer social functioning. The pathomechanism of GERD after SG is most likely multifactorial and tr…

medicine.medical_specialtySleeve gastrectomymedicine.medical_treatmentBariatric Surgery030209 endocrinology & metabolismDiseaseGeneral Biochemistry Genetics and Molecular BiologyEsophageal Sphincter LowerHiatal hernia03 medical and health sciences0302 clinical medicinePostoperative ComplicationsHistory and Philosophy of ScienceWeight lossGastrectomyWeight LossMedicineHumansObesityIntensive care medicinebusiness.industryGeneral Neurosciencemedicine.diseaseObesityhumanitiesdigestive system diseasesPathophysiologyHernia HiatalTreatment OutcomeGERDGastroesophageal Reflux030211 gastroenterology & hepatologyGastrectomymedicine.symptombusinessAnnals of the New York Academy of SciencesReferences
researchProduct

A body weight loss- and health-promoting gut microbiota is established after bariatric surgery in individuals with severe obesity

2020

Obesity has reached an epidemic level worldwide, and bariatric surgery (BS) has been proven to be the most efficient therapy to reduce severe obesity-related comorbidities. Given that the gut microbiota plays a causal role in obesity development and that surgery may alter the gut environment, investigating the impact of BS on the microbiota in the context of severe obesity is important. Although, alterations at the level of total gut bacteria, total gene content and total metabolite content have started to be disentangled, a clear deficit exists regarding the analysis of the active fraction of the microbiota, which is the fraction that is most reactive to the BS. Here, active gut microbiota…

medicine.medical_specialtySleeve gastrectomymedicine.medical_treatmentClinical BiochemistryGastric BypassPharmaceutical ScienceBariatric SurgeryContext (language use)Gut flora01 natural sciencesAnalytical ChemistryMetabolomicsDetoxificationDrug DiscoveryWeight LossmedicineHumansMicrobiomeSpectroscopybiology010405 organic chemistryChemistry010401 analytical chemistryMetabolismmedicine.diseasebiology.organism_classificationObesity0104 chemical sciencesSurgeryGastrointestinal MicrobiomeObesity Morbid
researchProduct